Menu
GeneBe

rs72558403

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate

The NM_000531.6(OTC):c.593A>G(p.Asn198Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N198I) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 23)

Consequence

OTC
NM_000531.6 missense

Scores

11
4
2

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 8.89
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM1
In a hotspot region, there are 13 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000531.6
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-38403670-A-T is described in ClinVar as [Pathogenic]. Clinvar id is 97262.Status of the report is no_assertion_criteria_provided, 0 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.994
PP5
Variant X-38403670-A-G is Pathogenic according to our data. Variant chrX-38403670-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 529422.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
OTCNM_000531.6 linkuse as main transcriptc.593A>G p.Asn198Ser missense_variant 6/10 ENST00000039007.5
OTCNM_001407092.1 linkuse as main transcriptc.593A>G p.Asn198Ser missense_variant 8/12
OTCXM_017029556.2 linkuse as main transcriptc.593A>G p.Asn198Ser missense_variant 6/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
OTCENST00000039007.5 linkuse as main transcriptc.593A>G p.Asn198Ser missense_variant 6/101 NM_000531.6 P1
OTCENST00000643344.1 linkuse as main transcriptc.*343A>G 3_prime_UTR_variant, NMD_transcript_variant 7/11
OTCENST00000488812.1 linkuse as main transcript downstream_gene_variant 5

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Ornithine carbamoyltransferase deficiency Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeMar 23, 2023For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asn198 amino acid residue in OTC. Other variant(s) that disrupt this residue have been observed in individuals with OTC-related conditions (PMID: 10070627, 16786505), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. ClinVar contains an entry for this variant (Variation ID: 529422). This missense change has been observed in individual(s) with clinical features of ornithine transcarbamylase deficiency (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 198 of the OTC protein (p.Asn198Ser). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.22
Cadd
Uncertain
25
Dann
Uncertain
1.0
DEOGEN2
Pathogenic
0.96
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.92
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.2
M
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.73
T
PROVEAN
Pathogenic
-5.0
D
REVEL
Pathogenic
0.93
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.018
D
Polyphen
1.0
D
Vest4
0.91
MutPred
0.95
Gain of sheet (P = 0.1208);
MVP
1.0
MPC
1.0
ClinPred
1.0
D
GERP RS
5.9
Varity_R
0.94
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72558403; hg19: chrX-38262923; API